NLRP3 and Cerebral ischemia: Several studies have revealed the beneficial effects of resveratrol in the treatment of AD (Qi et al., 2019), cerebral ischemia (He et al., 2017), and SAH (Zhang et al., 2017), all of which are closely related to the modulation of NLRP3 inflammasome.